Literature DB >> 16677799

Gene expression profiling of adrenal cortical tumors by cDNA macroarray analysis. Results of a preliminary study.

C P Lombardi1, M Raffaelli, G Pani, A Maffione, P Princi, E Traini, T Galeotti, E D Rossi, G Fadda, R Bellantone.   

Abstract

Adrenocortical carcinoma (ACC) are highly malignant tumors with poor prognosis. To verify if it is possible to assess their differential gene expression by a cDNA macroarray analysis using RNA extracted from paraffin sections, we analyzed two different cohorts of adrenal cortical adenoma (ACA) and ACC. Paraffin sections of seven ACC and seven ACA were analyzed. Transcriptional profiles were generated by commercially available c-DNA arrays testing 82 genes. Hybridization signals were quantified by densitometry and the intensity signal was compared for each gene between ACA and ACC cohorts. RNA was successfully extracted in only four out of 14 cases. Four genes displayed a significantly different expression (ACC/ACA ratio>1.5 or<0.6). Heat shock protein 60 (HSP-60) (ratio>2), Ciclin D1 and topoisomerase I (ratio>1.5) were overexpressed in the ACC cohort, while jun proto-oncogene was down-regulated. cDNA macroarray analysis from paraffin sections of adrenal tumors is feasible, despite with a low success rate. The different expression of HSP-60, Ciclin D1, jun proto-oncogene and topoisomerase I indicates that these genes may play a role in ACC pathogenesis and could represent potential diagnostic/prognostic/therapeutic target markers. Larger series of patients are necessary to confirm the biologic, diagnostic, prognostic and therapeutic implications of these findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677799     DOI: 10.1016/j.biopha.2006.03.006

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands.

Authors:  Tao Wang; Fumitoshi Satoh; Ryo Morimoto; Yasuhiro Nakamura; Hironobu Sasano; Richard J Auchus; Michael A Edwards; William E Rainey
Journal:  Eur J Endocrinol       Date:  2011-01-19       Impact factor: 6.664

2.  TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.

Authors:  Meenu Jain; Lisa Zhang; Mei He; Ya-Qin Zhang; Min Shen; Electron Kebebew
Journal:  Endocr Relat Cancer       Date:  2013-05-21       Impact factor: 5.678

Review 3.  The 'omics' of adrenocortical tumours for personalized medicine.

Authors:  Guillaume Assié; Anne Jouinot; Jérôme Bertherat
Journal:  Nat Rev Endocrinol       Date:  2014-02-04       Impact factor: 43.330

4.  Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma.

Authors:  Meenu Jain; Lisa Zhang; Mei He; Erin E Patterson; Naris Nilubol; Antonio T Fojo; Bharat Joshi; Raj Puri; Electron Kebebew
Journal:  Cancer       Date:  2012-05-08       Impact factor: 6.860

5.  KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer.

Authors:  Meenu Jain; Lisa Zhang; Erin E Patterson; Electron Kebebew
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

6.  Identification of four hub genes associated with adrenocortical carcinoma progression by WGCNA.

Authors:  Wang-Xiao Xia; Qin Yu; Gong-Hua Li; Yao-Wen Liu; Fu-Hui Xiao; Li-Qin Yang; Zia Ur Rahman; Hao-Tian Wang; Qing-Peng Kong
Journal:  PeerJ       Date:  2019-03-14       Impact factor: 2.984

7.  Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.

Authors:  Sudheer Kumar Gara; Yonghong Wang; Dhaval Patel; Yi Liu-Chittenden; Meenu Jain; Myriem Boufraqech; Lisa Zhang; Paul S Meltzer; Electron Kebebew
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.